[1] |
Qu RZ, Ma YP, Zhang ZP, et al. Increasing burden of colorectal cancer in China[J]. Lancet Gastroenterol Hepatol, 2022, 7(8): 700.
|
[2] |
Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480.
|
[3] |
Vitetta L, Chen JZ, Clarke S. The vermiform appendix: an immunological organ sustaining a microbiome inoculum[J]. Clin Sci, 2019, 133(1): 1-8.
|
[4] |
Constantin M, Petrescu L, Mătanie C, et al. The vermiform appendix and its pathologies[J]. Cancers, 2023, 15(15): 3872. https://doi.org/10.3390/cancers15153872.
|
[5] |
Rothwell JA, Mori N, Artaud F, et al. Colorectal cancer risk following appendectomy: a Pooled analysis of three large ProsPective cohort studies[J]. Cancer Commun(Lond), 2022, 42(5): 486-489.
|
[6] |
Liu Z, Ma X, Zhu C, et al. Risk of colorectal cancer after aPPendectomy: a systematic review and meta-analysis[J]. J Gastroenterol HePatol, 2023, 38(3): 350-358.
|
[7] |
Wu SC, Chen WT, Muo CH, et al. Association between appendectomy and subsequent colorectal cancer development: an Asian population study[J]. PLoS One, 2015, 10(2): e0118411. doi:10.1371/journal.pone.0118411.
|
[8] |
Shi F, Liu G, Lin Y, et al. Altered gut microbiome composition by appendectomy contributes to colorectal cancer[J]. Oncogene. 2023, 42(7): 530-540.
|
[9] |
Yun Z, Guo Z, Li X, et al. Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization study[J]. Cancer Med, 2023, 12(12): 13784-13799.
|
[10] |
Suzuki S, Goto A, Nakatochi M, et al. Body mass index and colorectal cancer risk: a Mendelian randomization study[J]. Cancer Sci, 2021, 112(4): 1579-1588.
|
[11] |
Wang L, Cao W, Xi MH, et al. Appendectomy and the risk of neurodegenerative diseases: a two-sample Mendelian randomization study[J]. Asian J Surg, 2023, 47(1): 673-674.
|
[12] |
Lyon MS, Andrews SJ, Elsworth B, et al. The variant call format provides efficient and robust storage of GWAS summary statistics[J]. Genome Biol, 2021, 22(1): 32. doi:10.1186/s13059-020-02248-0.
|
[13] |
Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes[J]. Nat Genet, 2021, 53(10): 1415-1424.
|
[14] |
Li YW, Ye D, Zhou WK, et al. Alcohol consumption and colorectal cancer risk: a Mendelian randomization study[J]. Front Genet, 2022, 13: 967229. doi:10.3389/fgene.2022.967229.
|
[15] |
常鑫, 刘世佳, 韩璐. 服用阿司匹林与子宫内膜癌发病风险的孟德尔随机化关系[J]. 山东大学学报(医学版), 2023, 61(10): 58-62, 82. CHANG Xin, LIU Shijia, HAN Lu. A Mendelian randomization study of aspirin use and the risk of endometrial cancer[J]. Journal of Shandong University(Health Sciences), 2023, 61(10): 58-62, 82.
|
[16] |
Yang MY, Wan XJ, Zheng HS, et al. No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study[J]. Nutrients, 2023, 15(4): 1057. doi:10.3390/nu15041057.
|
[17] |
Murphy N, Song MY, Papadimitriou N, et al. Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis[J]. J Natl Cancer Inst, 2022, 114(5): 740-752.
|
[18] |
Cho YA, Lee J, Oh JH, et al. Genetic risk score, combined lifestyle factors and risk of colorectal cancer[J]. Cancer Res Treat, 2019, 51(3): 1033-1040.
|
[19] |
OSullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2022, 20(6): 1229-1240.
|
[20] |
Papadimitriou N, Bull CJ, Jenab M, et al. Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study[J]. BMC Med, 2023, 21(1): 5. doi:10.1186/s12916-022-02702-9.
|
[21] |
Sun J, Zhao J, Jiang F, et al. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human Plasma Proteome with genome[J]. Genome Med, 2023, 15(1): 75. doi: 10.1186/s13073-023-01229-9.
|
[22] |
Su YN, Hu YF, Xu YW, et al. Genetic causal relationship between age at menarche and benign oesophageal neoplasia identified by a Mendelian randomization study[J]. Front Endocrinol, 2023, 14: 1113765. doi:10.3389/fendo.2023.1113765.
|
[23] |
Jung SY, Papp JC, Sobel EM, et al. Mendelian randomization study: the association between metabolic pathways and colorectal cancer risk[J]. Front Oncol, 2020, 10: 1005. doi: 10.3389/fonc.2020.01005.
|
[24] |
Chan II, Kwok MK, Schooling CM. Blood pressure and risk of cancer: a Mendelian randomization study[J]. BMC Cancer, 2021, 21(1): 1338. doi:10.1186/s12885-021-09067-x.
|
[25] |
Yuan S, Kar S, Carter P, et al. Is type 2 diabetes causally associated with cancer risk? evidence from a two-sample Mendelian randomization study[J]. Diabetes, 2020, 69(7): 1588-1596.
|
[26] |
Xiong J, Yang L, Deng YQ, et al. The causal association between smoking, alcohol consumption and risk of bladder cancer: a univariable and multivariable Mendelian randomization study[J]. Int J Cancer, 2022, 151(12): 2136-2143.
|
[27] |
Yuan S, Mason AM, Titova OE, et al. Morning chronotype and digestive tract cancers: Mendelian randomization study[J]. Int J Cancer, 2023, 152(4): 697-704.
|
[28] |
Chen X, Kong JQ, Diao XY, et al. Depression and prostate cancer risk: a Mendelian randomization study[J]. Cancer Med, 2020, 9(23): 9160-9167.
|
[29] |
Tan H, Wang SS, Huang FF, et al. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study[J]. Front Endocrinol, 2023, 14: 1138149. doi:10.3389/fendo.2023.1138149.
|
[30] |
Zhou X, Wang L, Xiao J, et al. Alcohol consumption, dna methylation and colorectal cancer risk: results from pooled cohort studies and mendelian randomization analysis[J]. Int J Cancer, 2022, 151(1): 83-94.
|
[31] |
Chen JZ, Sali A, Vitetta L. The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms[J]. Future Microbiol, 2020, 15: 541-555. doi:10.2217/fmb-2019-0325.
|
[32] |
Liang CS, Bai YM, Hsu JW, et al. The risk of Alzheimers disease after acute appendicitis with or without appendectomy[J]. J Am Med Dir Assoc, 2022, 23(4): 601-607.
|
[33] |
Shi F, Liu G, Lin Y, et al. Altered gut microbiome composition by appendectomy contributes to colorectal cancer[J]. Oncogene, 2023, 42(7): 530-540.
|
[34] |
高莹, 崔光星. 阑尾功能的再认识及急性阑尾炎的治疗进展[J]. 中国乡村医药, 2020, 27(18): 78-80. GAO Ying, CUI Guangxing. Re-understanding of appendix function and treatment progress of acute appendicitis[J]. Chinese Journal of Rural Medicine and Pharmacy, 2020, 27(18): 78-80.
|
[35] |
Arjomand Fard N, Armstrong H, Perry T, et al. Appendix and ulcerative colitis: a key to explaining the pathogenesis and directing novel therapies?[J]. Inflamm Bowel Dis, 2023, 29(1): 151-160.
|
[36] |
Quaglio AEV, Grillo TG, De Oliveira ECS, et al. Gut microbiota, inflammatory bowel disease and colorectal cancer[J]. World J Gastroenterol, 2022, 28(30): 4053-4060.
|
[37] |
Cheng YW, Ling ZX, Li LJ. The intestinal microbiota and colorectal cancer[J]. Front Immunol, 2020, 11: 615056. doi:10.3389/fimmu.2020.615056.
|
[38] |
Lin CZ, Cai XL, Zhang J, et al. Role of gut microbiota in the development and treatment of colorectal cancer[J]. Digestion, 2019, 100(1): 72-78.
|
[39] |
Ka zmierczak-Siedlecka K, Daca A, Fic M, et al. Therapeutic methods of gut microbiota modification in colorectal cancer management- fecal microbiota transplantation, prebiotics, probiotics, and synbiotics[J]. Gut Microbes, 2020, 11(6): 1518-1530.
|